News for Palisade Bio, Inc. (PALI)

Palisade Bio (PALI) has released encouraging topline results from its Phase 1 trials of PALI-2108, an innovative treatment targeting fibrostenotic Crohn's disea

Palatin Technologies, symbolized as (PALI), has joined forces with Kingswood Capital Partners and Ladenburg Thalmann as the principal book-running managers. Thi

On May 13, 2025, Brookline Capital analyst Kumaraguru Raja reiterated a "Buy" rating for Palisade Bio (PALI). The analyst has maintained the price target at USD

Palisade Bio (PALI) presents positive preclinical data for PALI-2108 at Digestive Disease Week 2025. PALI-2108 shows dose-dependent improvement in colit

**media[611637]**

Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, f

Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and t

**media[566623]**

Massachusetts-based iRobot Corporation (IRBT) is down over 35 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

**media[564380]**

Palisade Bio (PALI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment

**media[556934]**

**media[544696]**

Ohio-based Energy Focus, Inc. (EFOI) is up over 63 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

On December 31, 2024, Armistice Capital, LLC executed a significant transaction by acquiring 233,417 shares of Palisade Bio Inc at a price of $1.65 per share. T

**media[527327]**

PALI stock plunges to 52-week low, touches $1.34

**media[521491]**